During Monday’s Current trade, Shares of Vantiv Inc (NYSE:VNTV), gain 0.27% to $45.36.
Vantiv, Inc. (VNTV), a leading provider of payment processing services and related technology solutions for merchants and financial institutions of all sizes, declared that On Thursday, Sept. 17, Charles Drucker, chief executive officer at Vantiv, and Rozof will present at 10:20 a.m. PDT at the Deutsche Bank Technology Conference at The Cosmopolitan of Las Vegas hotel in Las Vegas.
Vantiv, Inc., through its partner, Vantiv Holding, LLC. provides payment processing services in the United States. It operates through two segments, Merchant Services and Financial Institution Services. The Merchant Services segment offers merchant acquiring and payment processing services, such as authorization and settlement, customer service, chargeback and retrieval processing, and interchange administration to merchants, and regional and small-to-mid sized businesses.
Shares of Anthem Inc (NYSE:ANTM), declined -0.50% to $146.36, during its current trading session.
A.M. Best has upgraded the financial strength rating to A- (Excellent) from B++ (Good) and the issuer credit rating to “a-” from “bbb” of Sterling Life Insurance Company (Sterling) (Chicago, IL). Additionally, A.M. Best has revised the under review implications status on the ratings to developing from positive.
The rating action follows the accomplished acquisition of Sterling by Cigna Corporation (Cigna) [NYSE:CI]. Sterling should benefit from Cigna’s financial strength and parental support if needed. The acquisition of Sterling fits Cigna’s strategy to further enhance the scale of its Medicare supplement business. The ratings of all Cigna’s auxiliaries remain under review with developing implication following the declarement of Cigna’s acquisition by Anthem, Inc. (Anthem) [NYSE:ANTM]. That acquisition is subject to multiple regulatory approvals and is predictable to close in late 2016.
Anthem, Inc., through its auxiliaries, operates as a health benefits company in the United States. It operates through three segments: Commercial and Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and senior markets.
Cerner Corporation(NASDAQ:CERN), during its Monday’s current trading session decreased -0.40% to $62.27.
Cerner, a global leader in health care technology, and CoverMyMeds, the nation’s leading electronic preceding authorization (ePA) platform, have declared a contract to integrate CoverMyMeds’ ePA within Cerner’s Millennium(R) EHR. The advanced functionality will provide more than 350,000 e-prescribing end users the ability to accelerate the prescription review process by removing manual processes and assist reduce transaction costs.
According to a 2012 study by the Center for Health Transformation, PA and other medication formulary requirements are noteworthy contributors to the cost of provider interaction with health plans, which exceeds $100 billion annually. The study also showed beyond the health care costs, PA requests can delay patient treatment and result in prescription abandonment.
Cerner Corporation designs, develops, markets, installs, hosts, and supports healthcare information technology, healthcare devices, hardware, and content solutions for healthcare organizations and consumers in the United States and internationally. The company offers Cerner Millennium architecture, which comprises clinical, financial, and administration information systems that allow providers to access an individual’s electronic health record at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front and back-office professionals, and consumers.
Finally, Mead Johnson Nutrition CO (NYSE:MJN), decreased -0.66%, to $75.12.
Mead Johnson Nutrition Company (MJN) declared that its board of directors has declared a regular quarterly dividend of $0.4125 per share for the quarter ending September 30, 2015.
The dividend will be paid on October 1, 2015, to shareholders of record at close of business on September 14, 2015.
Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, childrens nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for the use as the infant’s source of nutrition, in addition to a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfamil A+, and Enfalac A+ names; and solutions products to address common feeding tolerance problems, counting spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease and Enfamil A.R names.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
